Evaluation of Bone Mineral Density in Treatment-naive Patients with Human Immundeficiency Virus Infection
Journal Title: Turkish Journal of Osteoporosis - Year 2020, Vol 26, Issue 2
Abstract
Objective: Human Immundeficiency virus (HIV) infection is a risk factor for low bone mineral density (BMD). International HIV/AIDS guidelines do not recommend BMD screening for every patient. In this study, we aimed to compare the risk factors for the development of osteoporosis/osteopenia between patients with treatment naive HIV infection, to whom routine BMD screening is not recommended and patients with osteoporosis/osteopenia risk factors like men over 50 years of age, postmenopausal women to whom routine BMD screening is recommended. Materials and Methods: A database was created in which the demographic, clinical and laboratory features of patients with HIV infection were recorded in the infectious diseases outpatient clinic between January 2015 and June 2019. A total of 284 HIV-infected patients with dual-energy X-ray absorptiometry (DXA) measurements at admission and before antiretroviral treatment were included in the study. The characteristics of those aged ≥50 years/postmenopausal and <50 years naive HIV-infected patients with osteoporosis/osteopenia were compared. Results: Overall, 131 (46%) of 284 treatment-naive HIV-infected individuals were diagnosed with osteoporosis/osteopenia by DXA. The osteoporosis/osteopenia rate was 42.9% (106/247) and 67% (25/37) in those aged <50 and ≥50 years, respectively (p= 0.007). Osteoporosis was detected in 26 patients and 16 (61.5%) were <50 years. Further, decrease in BMD was most commonly observed in the femoral region among the elderly and in the lumbar and femoral regions among the young individuals (p<0.001). Conclusion: This study reveals a high rate of decrease in BMD among our young patients who were not exposed to antiretroviral therapy. The early detection of the presence of osteoporosis/osteopenia is important to increase the quality of life and to decrease the drug load. Therefore, we recommend performing diagnostic tests at any age in naive patients for low BMD detection and early treatment, regardless of the treatment.
Authors and Affiliations
Sevtap Şenoğlu, Özlem Altuntaş Aydın
Keywords
Related Articles
- EP ID EP688762
- DOI 10.4274/tod.galenos.2020.57704
- Views 119
- Downloads 0
A Rare Presentation of Primary Hyperparathyroidism: Generalized Brown Tumors
Primary hyperparathyroidism is a common and easily diagnosed disease at present. However, its complicated presentation as a brown tumour is rare. Here, we present the case of a patient with knee pain and common asymmetri...
Mechanisms and Causes of Osteoporotic Hip Fractures in Elderly Patients
Objective: To investigate the causes and occurrence mechanisms of osteoporotic hip fractures in elderly patients in Turkish society. Materials and Methods: This study included 83 consecutive patients who were operated i...
An Overview of the Musculoskeletal Comorbidity of Acromegaly: A Case with Non-traumatic Spontaneous Rectus Femoris Rupture
Acromegaly is a chronic endocrinopathy with pathologically increased levels of growth hormone (GH) and insulin-like growth factor-1 due to a pituitary adenoma that produces GH. One of the partially irreversible complicat...
Brown Tumor and Hyperparathyroidism in Orthopaedic Surgery
Objective: This study aimed a better diagnosis for patients with primary hyperparathyroidism (PHPT), who could be referred to misdiagnosis and treatment and be able to demonstrate a well analysis of patient before orthop...
Examination of the Etiologic Causes in Patients Presenting with Elevated Parathormone
Objective: Parathyroid hormone (PTH) levels are elevated in the blood due to various reasons and named as primary or secondary hyperparathyroidism. There is no any study that investigated the etiology of elevated PTH. M...